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Abstract 
Introduction: Localised bronchial obstruction is a rare differential 
diagnosis to asthma. 
Case study: We describe two younger patients treated unsuccessfully for 
asthma and eventually diagnosed with localised bronchoconstriction. 
Results: Bronchoscopy revealed bronchoconstriction: 
Tracheobronchomalacia in case 1 and fixed obstruction in case 2. 
Conclusion: A systematic approach to the asthma patient with absent 
response to therapy facilitates rational use of therapeutic and diagnostic 
resources. 
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Abstract: 
Introduction: Localised bronchial obstruction is a rare differential diagnosis to asthma.  
Case study: We describe two younger patients treated unsuccessfully for asthma and eventually 
diagnosed with localised bronchoconstriction. 
Results: Bronchoscopy revealed bronchoconstriction: Tracheobronchomalacia in case 1 and fixed 
obstruction in case 2. 
Conclusion: A systematic approach to the asthma patient with absent response to therapy 
facilitates rational use of therapeutic and diagnostic resources.   
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Introduction: 
Asthma is a common, inflammatory disease of the bronchial mucosa, leading to airway muscle 
constriction and general narrowing of the internal diameter of the peripheral bronchial tree (1). 
Asthma mimicking conditions do not respond to high-intensity asthma treatment and may therefore 
easily be mistaken for severe asthma (2). In the absence of response to pharmacological treatment 
of asthma, careful evaluation of adherence to therapy, potency of treatment, co-morbidity, 
exposure, as well as asthma diagnosis are mandatory (1,3). Inconsistencies between history, physical 
features and spirometry should heighten suspicion of an alternative diagnosis (4).  
In the following, we describe two younger patients treated unsuccessfully for asthma and eventually 
diagnosed with localised bronchoconstriction.  
Case study:  
Case 1: A 17-year old female was referred from her general practitioner (GP) due to refractory 
asthma. Since age 12, she had suffered from exercise-induced dyspnoea, becoming increasingly 
pronounced with age, paralleled by louder expiratory sounds. Birth and childhood were 
unremarkable with normal physical and mental development. She was physically active in and after 
school and was not the slowest runner in her class. She had no history of allergic conditions and no 
family history of cardio-pulmonary disease or allergy. She had been treated by her GP with inhaled 
corticosteroid and bronchodilators without subjective benefit. At physical examination, she had no 
signs of respiratory stress, or any trait suggesting developmental disorders. Lung auscultation was 
normal. Spirometry showed partly reversible airway obstruction (pre-[post] beta 2 agonist FEV1 2.0 L 
(62% of expected) [2.2 l (69%)];FEV1/FVC 70% [74%], Δ FEV1 11% (figure 1). A cardiac murmur was 
noted, but echocardiography revealed no signs of congenital or other heart diseases. Basic blood 
samples (haematology, liver and kidney function, and TSH) were all normal. A trial of 3 months of 
increased inhaled corticosteroids (ICS, dry powder 800 μg budesonide b.d.) and oral montelukast 
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q.d. failed to improve symptoms or spirometric values. High resolution (HR-)CT thorax, metacholine 
challenge test, exhaled nitrogen oxide (e-NO), and peak-flow diary were all normal. At 6-months 
follow-up, FEV1 had decreased to 60% of expected level. A flexible video-bronchoscopy in light 
sedation was performed (see results). She was referred for evaluation by thoracic surgeons who 
recommended watchful waiting until age 21. Medication was tapered off within a month without 
adverse events. Now, at age 20, her FEV1 is stable, and she only experiences tolerable exercise-
related dyspnoea. 
Case 2: A 39-year-old never-smoking woman with X-linked hypohidrotic ectodermal dysplasia (a 
rare genetic, usually X-linked recessive disorder affecting several ectodermal structures (5). The 
patients mother had same genetic disorder and was lung transplanted 15 years earlier) with slight 
facial abnormality, chronic sinusitis (treated surgically by ENT specialist) and chronic laryngitis 
(treated by logopedist) was admitted from specialized ENT-centre for asthma work-up. She had 
experienced slowly progressive exercise-induced dyspnoea and night-time coughing, interpreted as 
asthma by her GP and treated with terbutaline dry powder inhalation as needed. She was known 
allergic to grass pollen and had recurrent sinusitis with staphylococcus species. At physical 
examination, she presented a slight inspiratory stridor with predominance corresponding to right 
upper lobe bronchus, and lung function showed mild airway obstruction (FEV1 1.8 L (63%); FEV1/FVC 
63%) with no reversibility but flattening of inspiratory flow-volume curve suggesting intra-thoracic 
airway obstruction (figure 3a). Peak-flow was reduced to 200 mL (60% expected) but without diurnal 
variability. HR-CT was normal. Metacholine challenge was omitted. Body-plethysmography showed 
increased residual volume (160%) but was otherwise normal. She had normal basic blood samples 
including eosinophil count, except a mannose binding lectin just below lower limit. Intrathoracic 
obstruction was suspected, but she refused the offered bronchoscopy. Though not much pointed 
towards asthma, the patient and pulmonologist  agreed on a trial of three months of inhaled 
ICS/LABA (dry powder budesonide 800 μg + formoterole 9 μg b.d.). At follow-up, FEV1 had decreased 
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to 1.6 L. Bronchoscopic evaluation was re-offered but refused. She accepted referral for lung 
physiotherapy, and ENT re-evaluation (revealing insignificant slight oedema and reddening of first 
tracheal ring, but no stenosis). Five months later, she accompanied her mother at a consultation to 
the Regional Transplant Unit. Our colleagues noticed the clearly audible stridor and offered a 
bronchoscopy that she accepted. This confirmed a fixed bronchostenosis (see results). Medication 
was tapered off during 2 months without relapse. Now, 24 months later she maintains a normal lung 
function. She still has recurrent staphylococcal upper airway infection. Unfortunately, no endoscopic 
photos were saved. 
Results: 
Case 1: A flexible video-bronchoscopy revealed weakened cartilage structure between the right 
upper lobe bronchus - which continued to segment 2 only - and the right lateral part of the distal 
trachea where an abnormal bronchus led to the right segments 1 and 3. At forced expiration and 
voluntary coughing, we observed an almost complete collapse of the anterior wall of the lower 
trachea distally to the tracheal right overlap bronchus (figure 2). 
Case 2: Bronchoscopy showed narrowing of right main bronchus. Bronchoscopic dilatation with 
inflatable water balloon was repeated four times at the transplant unit, and FEV1 increased to 2.7 L 
(93%) and index 83% (figure 3b).  
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Discussion: 
It is of little surprise that the two patients were suspected having asthma by our non-specialist 
colleagues. Asthma is the most common chronic respiratory disease in adolescents and younger 
adult non-smokers (6, 7). GINA guidelines support that asthma diagnoses can be based solely on 
presence of asthma-like symptoms though preferably with supportive objective tests (8). As no 
symptom is pathognomonic for asthma, and differential diagnoses are numerous (1, 2, 4, 8), a 
careful and critical revision of the diagnosis is mandatory when patients are seen in tertiary units 
due to treatment failure (2, 4). The importance of considering asthma-mimicking conditions when 
asthma treatment does not work has been convincingly illustrated by Bel et al who presented an 
algorithm to optimise discrimination between difficult-to-manage-asthma and severe refractory 
asthma (2). Keeping the many differential diagnoses of difficult-to-manage-asthma in mind (table 1), 
Bel et al highlights the necessity of a systematic and extensive approach: Thorough medical history, 
medication adherence assessment, physical examination, spirometry, and bronchial challenge tests 
form the initial assessment; if negative, supplemented by a variety of targeted modalities to address 
differential diagnoses and co-morbidities and - lastly, tapering off asthma medication (1,2,3,4,7,9). 
Luks et al have presented a simple flowchart for stepwise reduction of asthma medications, and 
showed that nearly 30% of patients with primary care-diagnosed asthma referred to a pulmonology 
service had neither positive objective tests nor asthma symptoms after terminating medication (9). 
Keywords to alternative diagnoses for our two women were excellent self-reported adherence 
supported by prescription data from pharmacies, futile trials of guidelines-supported increases in 
anti-asthmatic treatment, presence of stridor in history, localised/fixed stridor at physical 
examination, and evident obstruction at spirometry with inspiratory flow-volume curves (10). 
Relevant differential diagnoses were addressed by medical history, physical examination, HR-CT and 
ENT evaluation. The gold standard for diagnosing localised bronchial abnormalities is bronchoscopy. 
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However, expiratory CT imaging and virtual tracheobronchoscopy have promising sensitivities above 
97% (11,12) but are not perfomed on a routine basis in our institution.  
Our two cases illustrate differences between dynamic and fixed obstruction. The first patient has 
tracheobronchomalacia (TBM), which is a weakness in the bronchial wall, defined as a narrowing of 
the lumen exceeding 50% in the expiratory phase (13). TBM is most commonly congenital, and this is 
probably the cause of TBM in our patient as well. TBM affects both bronchial and tracheal wall. 
Isolated bronchomalacia is rare. Secondary TBM may be caused by intubation, tracheotomy or 
infection or can be a result of prolonged compression including malignancy (13). Treatment depends 
on symptoms, cause and patient’s age: Tracheostomy, continuous positive airway flow +/- 
mechanical ventilation, stents or surgical removal of affected area (13). In adults, the symptoms are 
generally milder than in patients with fixed obstruction, bronchostenosis. This too may be caused by 
intubation, tracheostomy or infection, as well as systemic inflammation or malignancy (10). Our 
patient suffered from a genetic disorder and had recurrent staphylococcal sinus infections: Neither 
have previously been reported to be associated with bronchostenosis. Microaspiration could be a 
possible but unproven mechanism. Treatment is based on severity and cause: Balloon dilatation, 
heat therapy, stenting or surgery. Our patient was eligible for balloon dilatation, and the treatment 
remains efficacious 24 months later.  
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Conclusion: 
In summary, localised bronchial obstruction is a rare differential diagnosis to asthma. Localised 
bronchial obstruction may be dynamic or fixed. Knowledge of asthma mimicking condition and a 
systematic approach to the asthma patient with treatment failure facilitates rational use of 
therapeutic and diagnostic resources (1, 2, 4, 8, 9). 
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Figures:  
 
 
  
Fig. 1 
Fig. 2a Fig. 2b 
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Fig. 3a 
Fig. 3b 
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 Table 1 
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Figure- and table captions: 
Figure 1. Case 1: Lung function test showing flattened expiratory curve with near-significant 
reversibility for beta-2-agonists. 
Figure 2. Case 1: Bronchoscopic view of open right main bronchus during unforced breathing (a), 
but closed during forced expiration (b). 
Figure 3. Case 2: Forced flow-volume and volume time curves showing flattened, “box-like” in- 
and expiratory curves before balloon dilatation (a), and normalisation hereafter (b). 
Table 1: Diseases that can masquerade as severe asthma. Reproduced from Reference 4 with the 
permission of the publisher. 
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